Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 14, 2025

The Role of Galectin-3 as a Biomarker in the Cardio-Renal-Metabolic Pathology Axis.

View Full Paper
Ask AI
Bookmark
Share

Authors

OBOana Nicoleta Buliga-FinișAOAnca OuatuDTDaniela Maria Tănase

Discussion

Loading...

Member takes

Overview

This review highlights galectin-3's role as a key biomarker for cardiac and renal dysfunction in diabetes, indicating its clinical significance.

Key Points

  • Elevated levels of galectin-3 predict increased risk of cardiovascular disease and kidney failure.
  • Research indicates that galectin-3 is a significant biomarker for early detection of cardio-renal injury in diabetic individuals.
  • Galectin-3 overexpression is linked with various conditions, including chronic kidney disease and diabetes mellitus.
  • Utilizing galectin-3 assessment could enhance diagnostic accuracy and personalize treatment for complex metabolic disorders.

Cite This Study

Buliga-Finiș et al. (2025) studied this question.

synapsesocial.com/papers/68d4203f713b0b5dfea687dehttps://doi.org/10.3390/jcm14176071
View Full Paper
Ask AI
Bookmark
Share